We looked at the beneficial effects of SRT1720, a Sirt1 activator [27,28,29,30], Oroxylin-A, a Sirt3 activator [31,32,33], and their combination in insulin resistance/pre-diabetic rat heart. The gene discussed is SIRT3; the disease is Insulin resistance.